Nevertheless, increasing AFP values are associated with lower survival and higher tumor recurrence rate in patients at very early or early stages [103,104,105,106], as well as poor prognosis in patients with advanced HCC [107]. This evidence concerns the gene AFP and hepatocellular carcinoma.